A formula proven to improve joint health in athletes and seniors

Date: 05.03.2024Source: Activ'Inside

Activ’Inside has unveiled its latest innovation in joint care – AiFlex’inside™. Responding to the increasing apprehensions of consumers regarding joint health, AiFlex’inside™ aims to establish new benchmarks for joint health, mobility, and overall well-being, specifically catering to the needs of athletes and seniors. Formulated primarily with natural botanical ingredients proven to possess anti-inflammatory properties and to decrease pain sensitivity, AiFlex’inside™ not only targets joint discomfort but also enhances crucial factors for both athletes and seniors, such as sports performance and overall quality of life.

Joint health is a prevalent concern for consumers worldwide, with nearly half of them expressing the desire to move freely and effortlessly as the defining factor for good joint health. According to recent statistics, 48% of individuals emphasise the importance of being able to move without suffering from aches and pains, while 34% actively seek nutritional supplements with claims focused on improving bone and joint health.

In response to these prevalent challenges, Activ’Inside proudly presents AiFlex’inside™, a solution meticulously formulated with meadowsweet, saffron, and vitamin C. This targeted formula not only addresses existing joint concerns but also proactively promotes mobility, catering to the specific needs and desires expressed by consumers.

Scientifically Proven Efficacy: AiFlex’inside™ contains a patented saffron extract, backed by a proprietary clinical ex vivo study demonstrating a reduction in inflammation. This evidence supports its efficacy in addressing joint concerns. The formula also contains meadowsweet which has a proven mechanism of action for a pain decreasing effect.

Rheumatologist Approved: In a rheumatologist-supervised open trial with 100 participants, involving both athletes and seniors experiencing joint discomfort, AiFlex’inside™ showcased a confirmed decrease in discomfort with a daily 100mg dosage over a two-month period. This solidifies its position as a trustworthy solution for consumers aiming for peak joint health.

Backed by Official Recognition and User Affirmation: AiFlex’inside™ not only boasts a range of pending-claims from EFSA and consumers but also stands out with 82% of athletes expressing reduced exercise challenges, underlining its adaptability for diverse lifestyles. 72% of seniors incorporating AiFlex’inside™ into their routine witness a remarkable enhancement in their quality of life, affirming its profound positive influence on overall well-being.

Sign up to tune into our webinar ‘Flexibility and Fitness – A Joint Venture for a Healthier Life with AiFlex’inside™’ taking place on 21st March at 10:30 (UTC +1) or for more visit activinside.com

David Cox / IDM

Print article (with images) Print article (without images)


Always stay up to date and sign up for our newsletter service: